JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael K. Pasque
Marci S. Bailey
Nader Moazami
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shah, N. R.
Right arrow Articles by Moazami, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shah, N. R.
Right arrow Articles by Moazami, N.
Related Collections
Right arrow Transplantation - heart

J Thorac Cardiovasc Surg 2004;127:1481-1485
© 2004 The American Association for Thoracic Surgery

Cardiothoracic transplantation

Survival of patients removed from the heart transplant waiting list

Nirav R. Shah, BAa, Joseph G. Rogers, MDb, Gregory A. Ewald, MDb, Michael K. Pasque, MDa, Edward M. Geltman, MDb, Marci S. Bailey, RNa, Nader Moazami, MDa,*

a Division of Cardiothoracic Surgery, Washington University School of Medicine, St Louis, Mo, USA,
b Division of Cardiology, Washington University School of Medicine, St Louis, Mo, USA

Presented at the annual meeting of The American Transplant Congress, Washington, DC, June 2003.

Received for publication August 24, 2003; revisions received November 4, 2003; accepted for publication December 9, 2003.

* Address for reprints: Nader Moazami, MD, Washington University School of Medicine, Barnes-Jewish Hospital, Department of Surgery, Division of Cardiothoracic Surgery, Queeny Tower—Suite 3108, One Barnes-Jewish Hospital Plaza, St Louis, MO 63110, USA
moazamin{at}msnotes.wustl.edu

OBJECTIVE: End-stage heart failure has been associated with high mortality in the absence of transplantation. We evaluated the outcome of patients receiving optimal medical therapy who were removed from the cardiac transplant waiting list to determine survival and predictors of mortality.

METHODS: We performed a retrospective review of 27 patients removed from the cardiac transplant waiting list from 1999 to 2001 at our institution.

RESULTS: Mean age was 53 ± 11 years; 16 of the patients were male. Status was IB in 3 cases and II in 24. Median time on the list was 32 months, and median follow-up was 2.9 years. Patients were removed from the transplant list because of either clinical improvement (group A, n = 18) or deterioration (group B, n = 9). In group A, 13 patients had improved functional status and 10 were in New York Heart Association class 1 or 2; 16 had improved echocardiographic left ventricular function. Survivals at 3 years were 100% in group A and 44% in group B (P < .01).

CONCLUSION: Patients with end-stage heart failure who have clinical response to medical therapy have excellent 3-year survival. These data suggest the necessity of close evaluation of patients waiting for transplantation, with a low threshold for inactivation if persistent clinical improvement is observed.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.